Loading clinical trials...
Loading clinical trials...
Risk Identification of Long-term Complications in the Recover Patients With Severe COVID-19
The investigators retrospectively analyze the clinical characteristics of severe COVID-19 in our hospital, and then establish a prediction model for long-term complications in patients with severe COVID-19, and strengthen follow-up to improve the prognosis of patients.
At present, there is a lack of prediction models for the long-term complications of severe COVID-19. Therefore, the investigators used the hospital big data platform to retrospectively analyze the clinical characteristics of severe COVID-19 in our hospital, and conducted cohort follow-up of the changes in lung function including FEV1, FVC,FEV1% and DLCO, etc and and high-resolution CT of patients after discharge. COX model and other statistical methods were used to establish a prediction model for long-term complications of severe COVID-19, and early identification and intervention, strengthen follow-up, and improve the prognosis of patients.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
Yes
Follow-up of patients with severe COVID-19
Wuhan, China
Start Date
February 1, 2023
Primary Completion Date
September 30, 2024
Completion Date
November 1, 2025
Last Updated
May 8, 2024
500
ESTIMATED participants
Pulmonary rehabilitation
OTHER
Lead Sponsor
Wuhan Central Hospital
NCT05254990
NCT04745637
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions